연구
-
-
연구
-
연구업적
연구업적
최근 5년 연구업적 현황
| 연도 | 2024년 | 2023년 | 2022년 | 2021년 | 2020년 | |
|---|---|---|---|---|---|---|
| SCI 논문 발표편수 |
책임 | 179편 | 173편 | 163편 | 184편 | 135편 |
| 공동 | 147편 | 120편 | 115편 | 136편 | 168편 | |
| 합계 | 326편 | 293편 | 278편 | 320편 | 303편 | |
2297. Recurrence patterns after pancreaticoduodenectomy for ampullary cancer.
Kim H, Kwon W, Kim JR, Byun Y, Jang JY, Kim SW.
J Hepatobiliary Pancreat Sci. 2019
May;26(5):179-186.
Link
2296. The Implication of Cytogenetic Alterations in Pancreatic Ductal Adenocarcinoma and Intraductal Papillary Mucinous Neoplasm Identified by Fluorescence In Situ Hybridization and Their Potential Diagnostic Utility.
Lim CS, Im K, Lee DS, Kwon W, Kim JR, Han Y, Kim SW, Jang JY.
Gut Liver. 2019 Sep 20.
Link
2295. Chronological changes in epidemiologic features of patients with gallstones over the last 20 years in a single large-volume Korean center.
Zhao J, Kim H, Han Y, Choi YJ, Byun Y, Kwon W, Jang JY.
Mol Cancer Ther. 2018 Dec;17(12):2507-2518
Link
2294. Clinical validation of the 2017 international consensus guidelines on intraductal papillary mucinous neoplasm of the pancreas.
Kang JS, Park T, Han Y, Lee S, Lim H, Kim H, Kim SH, Kwon W, Kim SW, Jang JY.
Ann Surg Treat Res. 2019
Aug;97(2):58-64
Link
2293. Effects of preoperative malnutrition on Postoperative Surgical Outcomes and Quality of Life in Elderly Patients with Periampullary Neoplasms: A Single-Center Prospective Cohort Study.
Kim E1, Lee DH2, Jang JY2.
Gut Liver. 2019 Nov
15;13(6):690-697.
Link
2292. Palbociclib plus exemestane with gonadotropin-releasing hormone agonist versus capecitabine in premenopausal women with hormone receptor-positive, HER2-negative metastatic breast cancer (KCSG-BR15-10): a multicentre, open-label, randomised, phase 2 trial.
Park YH1, Kim TY2, Kim GM3, Kang SY4, Park IH5, Kim JH6, Lee KE7, Ahn HK8, Lee MH9, Kim HJ10, Kim HJ11, Lee JI12, Koh SJ13, Kim JY14, Lee KH2, Sohn J3, Kim SB15, Ahn JS14, Im YH14, Jung KH15, Im SA2; Korean Cancer Study Group (KCSG).
Lancet Oncol. 2019 Dec;20(12):1750-1759. doi: 10.1016/S1470-2045(19)30565-0. Epub 2019 Oct 24.
Link
2291. Overall Survival with Ribociclib plus Endocrine Therapy in Breast Cancer.
Im SA1, Lu YS1, Bardia A1, Harbeck N1, Colleoni M1, Franke F1, Chow L1, Sohn J1, Lee KS1, Campos-Gomez S1, Villanueva-Vazquez R1, Jung KH1, Chakravartty A1, Hughes G1, Gounaris I1, Rodriguez-Lorenc K1, Taran T1, Hurvitz S1, Tripathy D1.
N Engl J Med. 2019 Jul 25;381(4):307-316. doi: 10.1056/NEJMoa1903765. Epub 2019 Jun 4.
Link
2290. Proposal of new TNM classification for gastric cancer: focusing on pN3b and cytology-positive (CY1) disease.
Kim SH, Lee HJ, Park JH, Choi JH, Park SH, Choe HN, Oh SY, Suh YS, Kong SH, Park DJ, Yang HK,.
J Gastric Cancer 2019 Sep;19(3):329-343
Link
2289. Observational Study of Gastric Cancer Patients Not Treated During Follow-Up.
Oh SY, Lee JH, Lee HJ, Kim TH, Huh YJ, Ahn HS, Suh YS, Kong SH, Kim GH, Ahn SJ, Kim SH, Choi Y, Yang HK,.
Ann Surg Oncol 2019 2019 Sep;26(9):2905-2911
Link
2288. Operation time as a simple indicator to predict the overcoming of the learning curve in gastric cancer surgery: a multicenter cohort study.
Kim TH, Ryu KW, Lee JH, Cho GS, Hyung WJ, Kim CY, Kim MC, Ryu SW, Shin DW, Lee HJ,.
Gastric Cancer. 2019 Sep;22(5):1069-1080
Link